Calculating a person's risk of developing prostate cancer using results from two blood markers would improve the accuracy of screening for the disease, reports a new study led by a UCL researcher.

Prostate cancer is the most commonly diagnosed cancer in men. In the August 23 Nature, Saravana Dhanasekaran and colleagues from the University of Michigan Medical School describe the use of cDNA ...

Molecular diagnostics is a rapidly evolving area of surgical pathology, that is gradually beginning to transform our diagnostical procedures for a variety of tumors. Next to molecular prognostication ...